MMP14 and inflammatory bowel disease: In mouse models, endothelial cells lacking MT1-MMP exhibit limited IA, resulting in better tissue perfusion, preserved intestinal morphology, and a lower disease activity index, indicating that MT1-MMP is a potential therapeutic target for IBD.